Segment disclosures

Company overview

STERIS plc

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

55 dimension combinations 746 retained observations 31 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Applied Sterilization Technologies

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30297600000 USD20260807Open filing evidence
2025-04-01 – 2026-03-311138500000 USD20260529Open filing evidence
2025-04-01 – 2025-12-31849300000 USD20260206Open filing evidence
2025-04-01 – 2025-09-30562700000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30281200000 USD20260807Open filing evidence
2024-04-01 – 2025-03-311038600000 RestatedUSD20260529Open filing evidence
2024-04-01 – 2024-12-31764700000 USD20260206Open filing evidence
2024-04-01 – 2024-09-30506500000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30249800000 USD20250807Open filing evidence
2023-04-01 – 2024-03-31954000000 RestatedUSD20260529Open filing evidence
2022-04-01 – 2023-03-31914431000 USD20250529Open filing evidence

Operating Segments · Healthcare

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-09-302008500000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30974700000 USD20250807Open filing evidence
2024-04-01 – 2025-03-313878671000 USD20250529Open filing evidence
2024-04-01 – 2024-09-301845500000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30901200000 USD20250807Open filing evidence
2023-04-01 – 2024-03-313613019000 USD20250529Open filing evidence
2022-04-01 – 2023-03-313085131000 USD20250529Open filing evidence

Operating Segments · Healthcare Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301048300000 USD20260807Open filing evidence
2025-04-01 – 2026-03-314208600000 USD20260529Open filing evidence
2025-04-01 – 2025-12-313072300000 USD20260206Open filing evidence
2025-04-01 – 2025-06-30974700000 USD20260807Open filing evidence
2024-04-01 – 2025-03-313878700000 USD20260529Open filing evidence
2024-04-01 – 2024-12-312821500000 USD20260206Open filing evidence
2023-04-01 – 2024-03-313613000000 USD20260529Open filing evidence

Operating Segments · Life Science

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30146700000 USD20260807Open filing evidence
2025-04-01 – 2025-12-31425900000 USD20260206Open filing evidence
2025-04-01 – 2025-09-30280200000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30135200000 USD20260807Open filing evidence
2024-04-01 – 2024-12-31392800000 USD20260206Open filing evidence
2024-04-01 – 2024-09-30256400000 USD20251106Open filing evidence

Operating Segments · Life Science Member

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2026-03-31588800000 USD20260529Open filing evidence
2025-04-01 – 2025-06-30135200000 USD20250807Open filing evidence
2024-04-01 – 2025-03-31542300000 RestatedUSD20260529Open filing evidence
2024-04-01 – 2024-06-30128500000 USD20250807Open filing evidence
2023-04-01 – 2024-03-31571700000 RestatedUSD20260529Open filing evidence
2022-04-01 – 2023-03-31536704000 USD20250529Open filing evidence

Capitalequipmentrevenues · Applied Sterilization Technologies

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301400000 USD20260807Open filing evidence
2025-04-01 – 2026-03-3120000000 USD20260529Open filing evidence
2025-10-01 – 2025-12-3110200000 USD20260206Open filing evidence
2025-04-01 – 2025-12-3113900000 USD20260206Open filing evidence
2025-07-01 – 2025-09-302100000 USD20251106Open filing evidence
2025-04-01 – 2025-09-303700000 USD20251106Open filing evidence
2025-04-01 – 2025-06-301600000 USD20260807Open filing evidence
2024-04-01 – 2025-03-3130900000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-315000000 RestatedUSD20260206Open filing evidence
2024-04-01 – 2024-12-3114900000 RestatedUSD20260206Open filing evidence
2024-07-01 – 2024-09-308800000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-09-309900000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-06-301100000 USD20250807Open filing evidence
2023-04-01 – 2024-03-3114500000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-315241000 USD20250207Open filing evidence
2023-04-01 – 2023-12-317869000 USD20250207Open filing evidence
2023-07-01 – 2023-09-301754000 USD20241107Open filing evidence
2023-04-01 – 2023-09-302628000 USD20241107Open filing evidence
2022-04-01 – 2023-03-3126460000 USD20250529Open filing evidence

Capitalequipmentrevenues · Healthcare

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-30259400000 USD20251106Open filing evidence
2024-07-01 – 2024-09-30249700000 USD20251106Open filing evidence

Capitalequipmentrevenues · Healthcare Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2024-12-31254804000 USD20250207Open filing evidence
2024-04-01 – 2024-12-31719175000 USD20250207Open filing evidence
2024-07-01 – 2024-09-30249732000 USD20241107Open filing evidence
2024-04-01 – 2024-09-30464371000 USD20241107Open filing evidence
2023-10-01 – 2023-12-31266838000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31759842000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30254905000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30493004000 USD20241107Open filing evidence
2022-10-01 – 2022-12-31227226000 USD20230208Open filing evidence
2022-04-01 – 2022-12-31618844000 USD20230208Open filing evidence
2022-07-01 – 2022-09-30212484000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30391618000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30179134000 USD20220808Open filing evidence
2021-10-01 – 2021-12-31217214000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31570509000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30202405000 USD20211108Open filing evidence
2021-04-01 – 2021-09-30353295000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30150890000 USD20220808Open filing evidence
2020-10-01 – 2020-12-31147855000 USD20220209Open filing evidence
2020-04-01 – 2020-12-31407610000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30131673000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30259755000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30128082000 USD20200807Open filing evidence
2019-10-01 – 2019-12-31155408000 USD20210209Open filing evidence
2019-04-01 – 2019-12-31428894000 USD20210209Open filing evidence
2019-04-01 – 2019-06-30120855000 USD20200807Open filing evidence

Capitalequipmentrevenues · Healthcare Products Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareProductsMemberMember
PeriodValueUnitFiledEvidence
2019-04-01 – 2020-03-31592436000 USD20200529Open filing evidence
2019-10-01 – 2019-12-31148016000 USD20200210Open filing evidence
2019-04-01 – 2019-12-31410249000 USD20200210Open filing evidence
2019-07-01 – 2019-09-30147037000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-30262233000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-30115196000 USD2019-08-07 · 16:35:51.000ZOpen filing evidence
2018-04-01 – 2019-03-31568811000 USD20200529Open filing evidence
2018-10-01 – 2018-12-31143180000 USD20200210Open filing evidence
2018-04-01 – 2018-12-31384086000 USD20200210Open filing evidence

Capitalequipmentrevenues · Healthcare Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30230500000 USD20260807Open filing evidence
2025-04-01 – 2026-03-311095900000 USD20260529Open filing evidence
2025-10-01 – 2025-12-31272100000 USD20260206Open filing evidence
2025-04-01 – 2025-12-31758800000 USD20260206Open filing evidence
2025-04-01 – 2025-09-30486700000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30227300000 USD20260807Open filing evidence
2024-04-01 – 2025-03-311037200000 USD20260529Open filing evidence
2024-10-01 – 2024-12-31254800000 USD20260206Open filing evidence
2024-04-01 – 2024-12-31719200000 USD20260206Open filing evidence
2024-04-01 – 2024-09-30464400000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30214600000 USD20250807Open filing evidence
2023-04-01 – 2024-03-311091500000 RestatedUSD20260529Open filing evidence
2022-04-01 – 2023-03-31896590000 USD20250529Open filing evidence

Capitalequipmentrevenues · Life Science

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3031300000 USD20260807Open filing evidence
2025-10-01 – 2025-12-3133300000 USD20260206Open filing evidence
2025-04-01 – 2025-12-3191900000 USD20260206Open filing evidence
2025-07-01 – 2025-09-3031900000 USD20251106Open filing evidence
2025-04-01 – 2025-09-3058600000 USD20251106Open filing evidence
2025-04-01 – 2025-06-3026600000 USD20260807Open filing evidence
2024-10-01 – 2024-12-3131100000 USD20260206Open filing evidence
2024-04-01 – 2024-12-3180600000 USD20260206Open filing evidence
2024-07-01 – 2024-09-3023000000 USD20251106Open filing evidence
2024-04-01 – 2024-09-3049500000 USD20251106Open filing evidence

Capitalequipmentrevenues · Life Science Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2026-03-31135700000 USD20260529Open filing evidence
2025-04-01 – 2025-06-3026600000 USD20250807Open filing evidence
2024-04-01 – 2025-03-31117500000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-3131063000 USD20250207Open filing evidence
2024-04-01 – 2024-12-3180551000 USD20250207Open filing evidence
2024-07-01 – 2024-09-3023012000 USD20241107Open filing evidence
2024-04-01 – 2024-09-3049488000 USD20241107Open filing evidence
2024-04-01 – 2024-06-3026500000 USD20250807Open filing evidence
2023-04-01 – 2024-03-31155500000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-3144836000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31111265000 USD20250207Open filing evidence
2023-07-01 – 2023-09-3035438000 USD20241107Open filing evidence
2023-04-01 – 2023-09-3066429000 USD20241107Open filing evidence
2022-04-01 – 2023-03-31147420000 USD20250529Open filing evidence
2022-10-01 – 2022-12-3128581000 USD20230208Open filing evidence
2022-04-01 – 2022-12-3199095000 USD20230208Open filing evidence
2022-04-01 – 2022-06-3040499000 USD20220808Open filing evidence
2021-10-01 – 2021-12-3130412000 USD20230208Open filing evidence
2021-04-01 – 2021-12-3197343000 USD20230208Open filing evidence
2021-04-01 – 2021-06-3032745000 USD20220808Open filing evidence
2020-10-01 – 2020-12-3128993000 USD20220209Open filing evidence
2020-04-01 – 2020-12-3188664000 USD20220209Open filing evidence
2020-04-01 – 2020-06-3030430000 USD20200807Open filing evidence
2019-04-01 – 2020-03-31112747000 USD20200529Open filing evidence
2019-10-01 – 2019-12-3131762000 USD20210209Open filing evidence
2019-04-01 – 2019-12-3184993000 USD20210209Open filing evidence
2019-07-01 – 2019-09-3026462000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-3053231000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-3026769000 USD20200807Open filing evidence
2018-04-01 – 2019-03-31102714000 USD20200529Open filing evidence
2018-10-01 – 2018-12-3123363000 USD20200210Open filing evidence
2018-04-01 – 2018-12-3172289000 USD20200210Open filing evidence

Consumablerevenues · Healthcare

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-30374200000 USD20251106Open filing evidence
2024-07-01 – 2024-09-30341700000 USD20251106Open filing evidence
2020-04-01 – 2021-03-31510946000 USD20210528Open filing evidence
2019-04-01 – 2020-03-31486425000 USD20210528Open filing evidence
2018-04-01 – 2019-03-31443851000 USD20210528Open filing evidence

Consumablerevenues · Healthcare Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2024-12-31358233000 USD20250207Open filing evidence
2024-04-01 – 2024-12-311043294000 USD20250207Open filing evidence
2024-07-01 – 2024-09-30341707000 USD20241107Open filing evidence
2024-04-01 – 2024-09-30685061000 USD20241107Open filing evidence
2023-10-01 – 2023-12-31329435000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31915741000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30306025000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30586306000 USD20241107Open filing evidence
2022-10-01 – 2022-12-31259810000 USD20230208Open filing evidence
2022-04-01 – 2022-12-31757892000 USD20230208Open filing evidence
2022-07-01 – 2022-09-30246050000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30498082000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30252032000 USD20220808Open filing evidence
2021-10-01 – 2021-12-31273750000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31750531000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30270089000 USD20211108Open filing evidence
2021-04-01 – 2021-09-30476781000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30206692000 USD20220808Open filing evidence
2020-10-01 – 2020-12-31148839000 USD20220209Open filing evidence
2020-04-01 – 2020-12-31355390000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30122797000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30206551000 USD20211108Open filing evidence
2020-04-01 – 2020-06-3083754000 USD20200807Open filing evidence
2019-04-01 – 2019-06-30116082000 USD20200807Open filing evidence

Consumablerevenues · Healthcare Products Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareProductsMemberMember
PeriodValueUnitFiledEvidence
2019-04-01 – 2020-03-31454518000 USD20200529Open filing evidence
2019-10-01 – 2019-12-31121517000 USD20200210Open filing evidence
2019-04-01 – 2019-12-31338691000 USD20200210Open filing evidence
2019-07-01 – 2019-09-30108392000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-30217174000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-30108782000 USD2019-08-07 · 16:35:51.000ZOpen filing evidence
2018-04-01 – 2019-03-31414969000 USD20200529Open filing evidence
2018-10-01 – 2018-12-31107451000 USD20200210Open filing evidence
2018-04-01 – 2018-12-31309545000 USD20200210Open filing evidence

Consumablerevenues · Healthcare Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30391900000 USD20260807Open filing evidence
2025-04-01 – 2026-03-311496600000 USD20260529Open filing evidence
2025-10-01 – 2025-12-31387100000 USD20260206Open filing evidence
2025-04-01 – 2025-12-311120200000 USD20260206Open filing evidence
2025-04-01 – 2025-09-30733200000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30358900000 USD20260807Open filing evidence
2024-04-01 – 2025-03-311396000000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-31358200000 USD20260206Open filing evidence
2024-04-01 – 2024-12-311043300000 USD20260206Open filing evidence
2024-04-01 – 2024-09-30685100000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30343400000 USD20250807Open filing evidence
2023-04-01 – 2024-03-311248400000 RestatedUSD20260529Open filing evidence
2022-04-01 – 2023-03-311050316000 USD20250529Open filing evidence

Consumablerevenues · Life Science

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3081500000 USD20260807Open filing evidence
2025-10-01 – 2025-12-3175900000 USD20260206Open filing evidence
2025-04-01 – 2025-12-31228500000 USD20260206Open filing evidence
2025-07-01 – 2025-09-3077200000 USD20251106Open filing evidence
2025-04-01 – 2025-09-30152500000 USD20251106Open filing evidence
2025-04-01 – 2025-06-3075300000 USD20260807Open filing evidence
2024-10-01 – 2024-12-3168700000 USD20260206Open filing evidence
2024-04-01 – 2024-12-31210600000 USD20260206Open filing evidence
2024-07-01 – 2024-09-3072100000 USD20251106Open filing evidence
2024-04-01 – 2024-09-30141900000 USD20251106Open filing evidence

Consumablerevenues · Life Science Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2026-03-31308300000 USD20260529Open filing evidence
2025-04-01 – 2025-06-3075300000 USD20250807Open filing evidence
2024-04-01 – 2025-03-31286700000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-3168676000 USD20250207Open filing evidence
2024-04-01 – 2024-12-31210619000 USD20250207Open filing evidence
2024-07-01 – 2024-09-3072125000 USD20241107Open filing evidence
2024-04-01 – 2024-09-30141943000 USD20241107Open filing evidence
2024-04-01 – 2024-06-3069800000 USD20250807Open filing evidence
2023-04-01 – 2024-03-31251600000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-3160072000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31181179000 USD20250207Open filing evidence
2023-07-01 – 2023-09-3059409000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30121107000 USD20241107Open filing evidence
2022-04-01 – 2023-03-31241114000 USD20250529Open filing evidence
2022-10-01 – 2022-12-3155610000 USD20230208Open filing evidence
2022-04-01 – 2022-12-31172587000 USD20230208Open filing evidence
2021-10-01 – 2021-12-3161096000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31179380000 USD20230208Open filing evidence
2020-04-01 – 2021-03-31215005000 USD20210528Open filing evidence
2020-10-01 – 2020-12-3149627000 USD20220209Open filing evidence
2020-04-01 – 2020-12-31164262000 USD20220209Open filing evidence
2020-04-01 – 2020-06-3058842000 USD20200807Open filing evidence
2019-04-01 – 2020-03-31185904000 USD20210528Open filing evidence
2019-10-01 – 2019-12-3146370000 USD20210209Open filing evidence
2019-04-01 – 2019-12-31132939000 USD20210209Open filing evidence
2019-07-01 – 2019-09-3042540000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-3086569000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-3044029000 USD20200807Open filing evidence
2018-04-01 – 2019-03-31161780000 USD20210528Open filing evidence

Servicerevenues · Applied Sterilization Technologies

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30296300000 USD20260807Open filing evidence
2025-04-01 – 2026-03-311118500000 USD20260529Open filing evidence
2025-10-01 – 2025-12-31276400000 USD20260206Open filing evidence
2025-04-01 – 2025-12-31835400000 USD20260206Open filing evidence
2025-07-01 – 2025-09-30279400000 USD20251106Open filing evidence
2025-04-01 – 2025-09-30559000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30279600000 USD20260807Open filing evidence
2024-04-01 – 2025-03-311007600000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-31253100000 RestatedUSD20260206Open filing evidence
2024-04-01 – 2024-12-31749800000 RestatedUSD20260206Open filing evidence
2024-07-01 – 2024-09-30247900000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-09-30496600000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-06-30248700000 USD20250807Open filing evidence
2023-04-01 – 2024-03-31939500000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-31229690000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31695214000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30233299000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30465524000 USD20241107Open filing evidence
2022-04-01 – 2023-03-31887971000 USD20250529Open filing evidence

Servicerevenues · Healthcare

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-30400100000 USD20251106Open filing evidence
2024-07-01 – 2024-09-30352800000 USD20251106Open filing evidence

Servicerevenues · Healthcare Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2024-12-31363007000 USD20250207Open filing evidence
2024-04-01 – 2024-12-311059026000 USD20250207Open filing evidence
2024-07-01 – 2024-09-30352791000 USD20241107Open filing evidence
2024-04-01 – 2024-09-30696019000 USD20241107Open filing evidence
2023-10-01 – 2023-12-31319954000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31929574000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30309126000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30609620000 USD20241107Open filing evidence
2022-07-01 – 2022-09-30274279000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30541639000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30267360000 USD20220808Open filing evidence
2021-07-01 – 2021-09-30271640000 USD20211108Open filing evidence
2021-04-01 – 2021-09-30516875000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30245235000 USD20220808Open filing evidence
2020-07-01 – 2020-09-30216457000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30404279000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30187822000 USD20200807Open filing evidence
2019-04-01 – 2019-06-30208795000 USD20200807Open filing evidence

Servicerevenues · Healthcare Products Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareProductsMemberMember
PeriodValueUnitFiledEvidence
2019-04-01 – 2020-03-31376244000 USD20200529Open filing evidence
2019-10-01 – 2019-12-3195820000 USD20200210Open filing evidence
2019-04-01 – 2019-12-31276481000 USD20200210Open filing evidence
2019-07-01 – 2019-09-3094852000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-30180661000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-3085809000 USD2019-08-07 · 16:35:51.000ZOpen filing evidence
2018-04-01 – 2019-03-31354648000 USD20200529Open filing evidence

Servicerevenues · Healthcare Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30425900000 USD20260807Open filing evidence
2025-04-01 – 2026-03-311616000000 USD20260529Open filing evidence
2025-10-01 – 2025-12-31404700000 USD20260206Open filing evidence
2025-04-01 – 2025-12-311193300000 USD20260206Open filing evidence
2025-04-01 – 2025-09-30788600000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30388500000 USD20260807Open filing evidence
2024-04-01 – 2025-03-311445400000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-31363000000 USD20260206Open filing evidence
2024-04-01 – 2024-12-311059000000 USD20260206Open filing evidence
2024-04-01 – 2024-09-30696000000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30343200000 USD20250807Open filing evidence
2023-04-01 – 2024-03-311273100000 RestatedUSD20260529Open filing evidence
2022-04-01 – 2023-03-311138225000 USD20250529Open filing evidence

Servicerevenues · Life Science

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3034000000 USD20260807Open filing evidence
2025-10-01 – 2025-12-3136500000 USD20260206Open filing evidence
2025-04-01 – 2025-12-31105600000 USD20260206Open filing evidence
2025-07-01 – 2025-09-3035800000 USD20251106Open filing evidence
2025-04-01 – 2025-09-3069100000 USD20251106Open filing evidence
2025-04-01 – 2025-06-3033300000 USD20260807Open filing evidence
2024-10-01 – 2024-12-3136600000 USD20260206Open filing evidence
2024-04-01 – 2024-12-31101600000 USD20260206Open filing evidence
2024-07-01 – 2024-09-3032800000 USD20251106Open filing evidence
2024-04-01 – 2024-09-3065000000 USD20251106Open filing evidence

Servicerevenues · Life Science Member

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=ste:ServicerevenuesMember;us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2026-03-31144800000 USD20260529Open filing evidence
2025-04-01 – 2025-06-3033300000 USD20250807Open filing evidence
2024-04-01 – 2025-03-31138100000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-3136643000 USD20250207Open filing evidence
2024-04-01 – 2024-12-31101635000 USD20250207Open filing evidence
2024-07-01 – 2024-09-3032808000 USD20241107Open filing evidence
2024-04-01 – 2024-09-3064992000 USD20241107Open filing evidence
2024-04-01 – 2024-06-3032200000 USD20250807Open filing evidence
2023-04-01 – 2024-03-31164600000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-3141658000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31118630000 USD20250207Open filing evidence
2023-07-01 – 2023-09-3038248000 USD20241107Open filing evidence
2023-04-01 – 2023-09-3076972000 USD20241107Open filing evidence
2022-04-01 – 2023-03-31148170000 USD20250529Open filing evidence
2022-10-01 – 2022-12-3137082000 USD20230208Open filing evidence
2022-04-01 – 2022-12-31107566000 USD20230208Open filing evidence
2022-07-01 – 2022-09-3038333000 USD20221109Open filing evidence
2022-04-01 – 2022-09-3070484000 USD20221109Open filing evidence
2021-10-01 – 2021-12-3136400000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31104983000 USD20230208Open filing evidence
2021-07-01 – 2021-09-3036393000 USD20221109Open filing evidence
2021-04-01 – 2021-09-3068583000 USD20221109Open filing evidence
2020-10-01 – 2020-12-3132180000 USD20210209Open filing evidence
2020-04-01 – 2020-12-3190444000 USD20210209Open filing evidence
2020-07-01 – 2020-09-3030624000 USD20201106Open filing evidence
2020-04-01 – 2020-09-3058264000 USD20201106Open filing evidence
2020-04-01 – 2020-06-3027640000 USD20200807Open filing evidence
2019-04-01 – 2020-03-31118288000 USD20200529Open filing evidence
2019-10-01 – 2019-12-3130641000 USD20210209Open filing evidence
2019-04-01 – 2019-12-3186276000 USD20210209Open filing evidence
2019-07-01 – 2019-09-3029648000 USD20201106Open filing evidence
2019-04-01 – 2019-09-3055635000 USD20201106Open filing evidence
2019-04-01 – 2019-06-3025987000 USD20200807Open filing evidence
2018-04-01 – 2019-03-31114064000 USD20200529Open filing evidence

Applied Sterilization Technologies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30295600000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30593200000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30297600000 USD20260807Open filing evidence
2025-04-01 – 2026-03-311138500000 USD20260529Open filing evidence
2025-10-01 – 2025-12-31286600000 USD20260206Open filing evidence
2025-04-01 – 2025-12-31849300000 USD20260206Open filing evidence
2025-07-01 – 2025-09-30281500000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30562700000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30281200000 USD20260807Open filing evidence
2024-04-01 – 2025-03-311038600000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-31258100000 RestatedUSD20260206Open filing evidence
2024-04-01 – 2024-12-31764700000 RestatedUSD20260206Open filing evidence
2024-07-01 – 2024-09-30256700000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-09-30506500000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-06-30249800000 RestatedUSD20250807Open filing evidence
2023-04-01 – 2024-03-31954000000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-31234931000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31703083000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30235053000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30468152000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30233099000 USD20240808Open filing evidence
2022-04-01 – 2023-03-31914431000 USD20250529Open filing evidence
2022-10-01 – 2022-12-31222014000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31675283000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30232358000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30453269000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30220911000 USD20230808Open filing evidence
2021-10-01 – 2021-12-31216298000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31630092000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30204892000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30413794000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30208902000 USD20220808Open filing evidence
2020-04-01 – 2021-03-31685912000 USD20210528Open filing evidence
2020-10-01 – 2020-12-31176462000 USD20220209Open filing evidence
2020-04-01 – 2020-12-31498371000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30169547000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30321909000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30152362000 USD20210809Open filing evidence
2019-04-01 – 2020-03-31627147000 USD20210528Open filing evidence
2019-10-01 – 2019-12-31156266000 USD20210209Open filing evidence
2019-04-01 – 2019-12-31463459000 USD20210209Open filing evidence
2019-07-01 – 2019-09-30152907000 USD20201106Open filing evidence
2019-04-01 – 2019-09-30307193000 USD20201106Open filing evidence
2019-04-01 – 2019-06-30154286000 USD20200807Open filing evidence
2018-04-01 – 2019-03-31555127000 USD20210528Open filing evidence

Applied Sterilization Technologies · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30295600000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30593200000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30281500000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30562700000 USD20261105Open filing evidence

Applied Sterilization Technologies · Capitalequipmentrevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember;srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301700000 USD20261105Open filing evidence
2026-04-01 – 2026-09-303100000 USD20261105Open filing evidence
2025-07-01 – 2025-09-302100000 USD20261105Open filing evidence
2025-04-01 – 2025-09-303700000 USD20261105Open filing evidence
2024-04-01 – 2024-06-301088000 USD20240808Open filing evidence
2023-10-01 – 2023-12-315241000 USD20240208Open filing evidence
2023-04-01 – 2023-12-317869000 USD20240208Open filing evidence
2023-07-01 – 2023-09-301754000 USD20231107Open filing evidence
2023-04-01 – 2023-09-302628000 USD20231107Open filing evidence
2023-04-01 – 2023-06-30874000 USD20240808Open filing evidence
2022-10-01 – 2022-12-313679000 USD20240208Open filing evidence
2022-04-01 – 2022-12-3114783000 USD20240208Open filing evidence
2022-07-01 – 2022-09-3010485000 USD20231107Open filing evidence
2022-04-01 – 2022-09-3011104000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30619000 USD20230808Open filing evidence

Applied Sterilization Technologies · Servicerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:AppliedSterilizationTechnologiesMember;srt:ProductOrServiceAxis=ste:ServicerevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30293900000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30590100000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30279400000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30559000000 USD20261105Open filing evidence
2024-04-01 – 2024-06-30248715000 USD20240808Open filing evidence
2023-10-01 – 2023-12-31229690000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31695214000 USD20240208Open filing evidence
2023-07-01 – 2023-09-30233299000 USD20231107Open filing evidence
2023-04-01 – 2023-09-30465524000 USD20231107Open filing evidence
2023-04-01 – 2023-06-30232225000 USD20240808Open filing evidence
2022-10-01 – 2022-12-31218335000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31660500000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30221873000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30442165000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30220292000 USD20230808Open filing evidence

Dental

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:DentalMember
PeriodValueUnitFiledEvidence
2023-10-01 – 2023-12-3197921000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31303233000 USD20240208Open filing evidence
2023-07-01 – 2023-09-30104156000 USD20231107Open filing evidence
2023-04-01 – 2023-09-30205312000 USD20231107Open filing evidence
2023-04-01 – 2023-06-30101156000 USD20230808Open filing evidence
2022-10-01 – 2022-12-31103563000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31317988000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30109578000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30214425000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30104847000 USD20230808Open filing evidence
2021-10-01 – 2021-12-31105090000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31255954000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30115632000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30150864000 USD20221109Open filing evidence
2021-04-01 – 2021-06-3035232000 USD20220808Open filing evidence
2020-10-01 – 2020-12-310 USD20220209Open filing evidence
2020-04-01 – 2020-12-310 USD20220209Open filing evidence
2020-07-01 – 2020-09-300 USD20211108Open filing evidence
2020-04-01 – 2020-09-300 USD20211108Open filing evidence
2020-04-01 – 2020-06-300 USD20210809Open filing evidence

Healthcare

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-301033800000 USD20251106Open filing evidence
2024-07-01 – 2024-09-30944200000 USD20251106Open filing evidence
2020-04-01 – 2021-03-311954055000 USD20210528Open filing evidence
2019-04-01 – 2020-03-311986809000 USD20210528Open filing evidence
2018-04-01 – 2019-03-311848485000 USD20210528Open filing evidence

Healthcare · Capitalequipmentrevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember;srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember
PeriodValueUnitFiledEvidence
2020-04-01 – 2021-03-31588864000 USD20210528Open filing evidence
2019-04-01 – 2020-03-31617712000 USD20210528Open filing evidence
2018-04-01 – 2019-03-31587680000 USD20210528Open filing evidence

Healthcare · Servicerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMember;srt:ProductOrServiceAxis=ste:ServicerevenuesMember
PeriodValueUnitFiledEvidence
2020-04-01 – 2021-03-31854245000 USD20210528Open filing evidence
2019-04-01 – 2020-03-31882672000 USD20210528Open filing evidence
2018-04-01 – 2019-03-31816954000 USD20210528Open filing evidence

Healthcare Member

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember
PeriodValueUnitFiledEvidence
2024-10-01 – 2024-12-31976044000 USD20250207Open filing evidence
2024-04-01 – 2024-12-312821495000 USD20250207Open filing evidence
2024-07-01 – 2024-09-30944230000 USD20241107Open filing evidence
2024-04-01 – 2024-09-301845451000 USD20241107Open filing evidence
2024-04-01 – 2024-06-30901221000 USD20240808Open filing evidence
2023-10-01 – 2023-12-31916227000 USD20250207Open filing evidence
2023-04-01 – 2023-12-312605157000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30870056000 USD20241107Open filing evidence
2023-04-01 – 2023-09-301688930000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30818874000 USD20240808Open filing evidence
2022-10-01 – 2022-12-31769144000 USD20240208Open filing evidence
2022-04-01 – 2022-12-312200483000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30732813000 USD20231107Open filing evidence
2022-04-01 – 2022-09-301431339000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30698526000 USD20230808Open filing evidence
2021-10-01 – 2021-12-31759675000 USD20230208Open filing evidence
2021-04-01 – 2021-12-312106626000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30744134000 USD20221109Open filing evidence
2021-04-01 – 2021-09-301346951000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30602817000 USD20220808Open filing evidence
2020-10-01 – 2020-12-31521662000 USD20220209Open filing evidence
2020-04-01 – 2020-12-311392247000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30470927000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30870585000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30399658000 USD20210809Open filing evidence
2019-10-01 – 2019-12-31509222000 USD20210209Open filing evidence
2019-04-01 – 2019-12-311440237000 USD20210209Open filing evidence
2019-07-01 – 2019-09-30485283000 USD20201106Open filing evidence
2019-04-01 – 2019-09-30931015000 USD20201106Open filing evidence
2019-04-01 – 2019-06-30445732000 USD20200807Open filing evidence

Healthcare Member · Capitalequipmentrevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember;srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30214639000 USD20240808Open filing evidence
2023-10-01 – 2023-12-31266838000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31759842000 USD20240208Open filing evidence
2023-04-01 – 2023-06-30238099000 USD20240808Open filing evidence
2022-10-01 – 2022-12-31227226000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31618844000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30212484000 USD20221109Open filing evidence
2022-04-01 – 2022-09-30391618000 USD20221109Open filing evidence
2022-04-01 – 2022-06-30179134000 USD20230808Open filing evidence
2021-07-01 – 2021-09-30202405000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30353295000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30150890000 USD20210809Open filing evidence
2020-07-01 – 2020-09-30131673000 USD20201106Open filing evidence
2020-04-01 – 2020-09-30259755000 USD20201106Open filing evidence
2020-04-01 – 2020-06-30128082000 USD20210809Open filing evidence
2019-07-01 – 2019-09-30152631000 USD20201106Open filing evidence
2019-04-01 – 2019-09-30273486000 USD20201106Open filing evidence

Healthcare Member · Consumablerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember;srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30343354000 USD20240808Open filing evidence
2023-10-01 – 2023-12-31329435000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31915741000 USD20240208Open filing evidence
2023-04-01 – 2023-06-30280281000 USD20240808Open filing evidence
2022-10-01 – 2022-12-31259810000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31757892000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30246050000 USD20221109Open filing evidence
2022-04-01 – 2022-09-30498082000 USD20221109Open filing evidence
2022-04-01 – 2022-06-30252032000 USD20230808Open filing evidence
2021-07-01 – 2021-09-30270089000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30476781000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30206692000 USD20210809Open filing evidence
2020-10-01 – 2020-12-31148839000 USD20210209Open filing evidence
2020-04-01 – 2020-12-31355390000 USD20210209Open filing evidence
2020-07-01 – 2020-09-30122797000 USD20201106Open filing evidence
2020-04-01 – 2020-09-30206551000 USD20201106Open filing evidence
2020-04-01 – 2020-06-3083754000 USD20210809Open filing evidence
2019-10-01 – 2019-12-31130255000 USD20210209Open filing evidence
2019-04-01 – 2019-12-31362370000 USD20210209Open filing evidence
2019-07-01 – 2019-09-30116033000 USD20201106Open filing evidence
2019-04-01 – 2019-09-30232115000 USD20201106Open filing evidence

Healthcare Member · Servicerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareMemberMember;srt:ProductOrServiceAxis=ste:ServicerevenuesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30343228000 USD20240808Open filing evidence
2023-10-01 – 2023-12-31319954000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31929574000 USD20240208Open filing evidence
2023-04-01 – 2023-06-30300494000 USD20240808Open filing evidence
2022-10-01 – 2022-12-31282108000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31823747000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30274279000 USD20221109Open filing evidence
2022-04-01 – 2022-09-30541639000 USD20221109Open filing evidence
2022-04-01 – 2022-06-30267360000 USD20230808Open filing evidence
2021-10-01 – 2021-12-31268711000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31785586000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30271640000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30516875000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30245235000 USD20210809Open filing evidence
2020-10-01 – 2020-12-31224968000 USD20220209Open filing evidence
2020-04-01 – 2020-12-31629247000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30216457000 USD20201106Open filing evidence
2020-04-01 – 2020-09-30404279000 USD20201106Open filing evidence
2020-04-01 – 2020-06-30187822000 USD20210809Open filing evidence
2019-10-01 – 2019-12-31223559000 USD20210209Open filing evidence
2019-04-01 – 2019-12-31648973000 USD20210209Open filing evidence
2019-07-01 – 2019-09-30216619000 USD20201106Open filing evidence
2019-04-01 – 2019-09-30425414000 USD20201106Open filing evidence

Healthcare Products Member

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareProductsMemberMember
PeriodValueUnitFiledEvidence
2019-04-01 – 2020-03-311423198000 USD20200529Open filing evidence
2019-10-01 – 2019-12-31365353000 USD20200210Open filing evidence
2019-04-01 – 2019-12-311025421000 USD20200210Open filing evidence
2019-07-01 – 2019-09-30350281000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-30660068000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-30309787000 USD2019-08-07 · 16:35:51.000ZOpen filing evidence
2018-04-01 – 2019-03-311338428000 USD20200529Open filing evidence

Healthcare Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301122400000 USD20261105Open filing evidence
2026-04-01 – 2026-09-302170800000 USD20261105Open filing evidence
2026-04-01 – 2026-06-301048300000 USD20260807Open filing evidence
2025-04-01 – 2026-03-314208600000 USD20260529Open filing evidence
2025-10-01 – 2025-12-311063800000 USD20260206Open filing evidence
2025-04-01 – 2025-12-313072300000 USD20260206Open filing evidence
2025-07-01 – 2025-09-301033800000 USD20261105Open filing evidence
2025-04-01 – 2025-09-302008500000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30974700000 USD20260807Open filing evidence
2024-04-01 – 2025-03-313878700000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-31976000000 USD20260206Open filing evidence
2024-04-01 – 2024-12-312821500000 USD20260206Open filing evidence
2024-04-01 – 2024-09-301845500000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30901200000 USD20250807Open filing evidence
2023-04-01 – 2024-03-313613000000 RestatedUSD20260529Open filing evidence
2022-04-01 – 2023-03-313085131000 USD20250529Open filing evidence

Healthcare Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301122400000 USD20261105Open filing evidence
2026-04-01 – 2026-09-302170800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-301033800000 USD20261105Open filing evidence
2025-04-01 – 2025-09-302008500000 USD20261105Open filing evidence

Healthcare Segment · Capitalequipmentrevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember;srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30270000000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30500500000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30259400000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30486700000 USD20261105Open filing evidence

Healthcare Segment · Consumablerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember;srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30411800000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30803800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30374200000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30733200000 USD20261105Open filing evidence

Healthcare Segment · Servicerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSegmentMember;srt:ProductOrServiceAxis=ste:ServicerevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30440600000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30866500000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30400100000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30788600000 USD20261105Open filing evidence

Healthcare Specialty Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:HealthcareSpecialtyServicesMember
PeriodValueUnitFiledEvidence
2019-04-01 – 2020-03-31563611000 USD20200529Open filing evidence
2019-10-01 – 2019-12-31143869000 USD20200210Open filing evidence
2019-04-01 – 2019-12-31414816000 USD20200210Open filing evidence
2019-07-01 – 2019-09-30135002000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-09-30270947000 USD2019-11-07 · 18:19:36.000ZOpen filing evidence
2019-04-01 – 2019-06-30135945000 USD2019-08-07 · 16:35:51.000ZOpen filing evidence
2018-04-01 – 2019-03-31510057000 USD20200529Open filing evidence

Life Science

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30170600000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30317400000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30146700000 USD20260807Open filing evidence
2025-10-01 – 2025-12-31145800000 USD20260206Open filing evidence
2025-04-01 – 2025-12-31425900000 USD20260206Open filing evidence
2025-07-01 – 2025-09-30145000000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30280200000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30135200000 USD20260807Open filing evidence
2024-10-01 – 2024-12-31136400000 USD20260206Open filing evidence
2024-04-01 – 2024-12-31392800000 USD20260206Open filing evidence
2024-07-01 – 2024-09-30127900000 USD20251106Open filing evidence
2024-04-01 – 2024-09-30256400000 USD20251106Open filing evidence

Life Science · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30170600000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30317400000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30145000000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30280200000 USD20261105Open filing evidence

Life Science · Capitalequipmentrevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember;srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3048900000 USD20261105Open filing evidence
2026-04-01 – 2026-09-3080100000 USD20261105Open filing evidence
2025-07-01 – 2025-09-3031900000 USD20261105Open filing evidence
2025-04-01 – 2025-09-3058600000 USD20261105Open filing evidence

Life Science · Consumablerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember;srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3084000000 USD20261105Open filing evidence
2026-04-01 – 2026-09-30165500000 USD20261105Open filing evidence
2025-07-01 – 2025-09-3077200000 USD20261105Open filing evidence
2025-04-01 – 2025-09-30152500000 USD20261105Open filing evidence

Life Science · Servicerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMember;srt:ProductOrServiceAxis=ste:ServicerevenuesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3037700000 USD20261105Open filing evidence
2026-04-01 – 2026-09-3071700000 USD20261105Open filing evidence
2025-07-01 – 2025-09-3035800000 USD20261105Open filing evidence
2025-04-01 – 2025-09-3069100000 USD20261105Open filing evidence

Life Science Member

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2026-03-31588800000 USD20260529Open filing evidence
2025-04-01 – 2025-06-30135200000 USD20250807Open filing evidence
2024-04-01 – 2025-03-31542300000 RestatedUSD20260529Open filing evidence
2024-10-01 – 2024-12-31136382000 USD20250207Open filing evidence
2024-04-01 – 2024-12-31392805000 USD20250207Open filing evidence
2024-07-01 – 2024-09-30127945000 USD20241107Open filing evidence
2024-04-01 – 2024-09-30256423000 USD20241107Open filing evidence
2024-04-01 – 2024-06-30128500000 RestatedUSD20250807Open filing evidence
2023-04-01 – 2024-03-31571700000 RestatedUSD20260529Open filing evidence
2023-10-01 – 2023-12-31146566000 USD20250207Open filing evidence
2023-04-01 – 2023-12-31411074000 USD20250207Open filing evidence
2023-07-01 – 2023-09-30133095000 USD20241107Open filing evidence
2023-04-01 – 2023-09-30264508000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30131413000 USD20240808Open filing evidence
2022-04-01 – 2023-03-31536704000 USD20250529Open filing evidence
2022-10-01 – 2022-12-31121273000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31379248000 USD20240208Open filing evidence
2022-07-01 – 2022-09-30125768000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30257975000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30132207000 USD20230808Open filing evidence
2021-10-01 – 2021-12-31127908000 USD20230208Open filing evidence
2021-04-01 – 2021-12-31381706000 USD20230208Open filing evidence
2021-07-01 – 2021-09-30132327000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30253798000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30121471000 USD20220808Open filing evidence
2020-04-01 – 2021-03-31467552000 USD20210528Open filing evidence
2020-10-01 – 2020-12-31110800000 USD20220209Open filing evidence
2020-04-01 – 2020-12-31343370000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30115658000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30232570000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30116912000 USD20210809Open filing evidence
2019-04-01 – 2020-03-31416939000 USD20210528Open filing evidence
2019-10-01 – 2019-12-31108773000 USD20210209Open filing evidence
2019-04-01 – 2019-12-31304208000 USD20210209Open filing evidence
2019-07-01 – 2019-09-3098650000 USD20201106Open filing evidence
2019-04-01 – 2019-09-30195435000 USD20201106Open filing evidence
2019-04-01 – 2019-06-3096785000 USD20200807Open filing evidence
2018-04-01 – 2019-03-31378558000 USD20210528Open filing evidence

Life Science Member · Capitalequipmentrevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember;srt:ProductOrServiceAxis=ste:CapitalequipmentrevenuesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-3026476000 USD20240808Open filing evidence
2023-10-01 – 2023-12-3144836000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31111265000 USD20240208Open filing evidence
2023-07-01 – 2023-09-3035438000 USD20231107Open filing evidence
2023-04-01 – 2023-09-3066429000 USD20231107Open filing evidence
2023-04-01 – 2023-06-3030991000 USD20240808Open filing evidence
2022-10-01 – 2022-12-3128581000 USD20240208Open filing evidence
2022-04-01 – 2022-12-3199095000 USD20240208Open filing evidence
2022-07-01 – 2022-09-3030015000 USD20231107Open filing evidence
2022-04-01 – 2022-09-3070514000 USD20231107Open filing evidence
2022-04-01 – 2022-06-3040499000 USD20230808Open filing evidence
2021-07-01 – 2021-09-3034186000 USD20221109Open filing evidence
2021-04-01 – 2021-09-3066931000 USD20221109Open filing evidence
2021-04-01 – 2021-06-3032745000 USD20210809Open filing evidence
2020-04-01 – 2021-03-31128356000 USD20210528Open filing evidence
2020-07-01 – 2020-09-3029241000 USD20211108Open filing evidence
2020-04-01 – 2020-09-3059671000 USD20211108Open filing evidence
2020-04-01 – 2020-06-3030430000 USD20210809Open filing evidence
2019-04-01 – 2020-03-31112747000 USD20210528Open filing evidence
2019-07-01 – 2019-09-3026462000 USD20201106Open filing evidence
2019-04-01 – 2019-09-3053231000 USD20201106Open filing evidence
2018-04-01 – 2019-03-31102714000 USD20210528Open filing evidence

Life Science Member · Consumablerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember;srt:ProductOrServiceAxis=ste:ConsumablerevenuesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-3069818000 USD20240808Open filing evidence
2023-10-01 – 2023-12-3160072000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31181179000 USD20240208Open filing evidence
2023-07-01 – 2023-09-3059409000 USD20231107Open filing evidence
2023-04-01 – 2023-09-30121107000 USD20231107Open filing evidence
2023-04-01 – 2023-06-3061698000 USD20240808Open filing evidence
2022-10-01 – 2022-12-3155610000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31172587000 USD20240208Open filing evidence
2022-07-01 – 2022-09-3057420000 USD20231107Open filing evidence
2022-04-01 – 2022-09-30116977000 USD20231107Open filing evidence
2022-04-01 – 2022-06-3059557000 USD20230808Open filing evidence
2021-07-01 – 2021-09-3061748000 USD20221109Open filing evidence
2021-04-01 – 2021-09-30118284000 USD20221109Open filing evidence
2021-04-01 – 2021-06-3056536000 USD20220808Open filing evidence
2020-07-01 – 2020-09-3055793000 USD20211108Open filing evidence
2020-04-01 – 2020-09-30114635000 USD20211108Open filing evidence
2020-04-01 – 2020-06-3058842000 USD20210809Open filing evidence
2019-07-01 – 2019-09-3042540000 USD20201106Open filing evidence
2019-04-01 – 2019-09-3086569000 USD20201106Open filing evidence

Life Science Member · Servicerevenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:LifeScienceMemberMember;srt:ProductOrServiceAxis=ste:ServicerevenuesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-3032184000 USD20240808Open filing evidence
2023-10-01 – 2023-12-3141658000 USD20240208Open filing evidence
2023-04-01 – 2023-12-31118630000 USD20240208Open filing evidence
2023-07-01 – 2023-09-3038248000 USD20231107Open filing evidence
2023-04-01 – 2023-09-3076972000 USD20231107Open filing evidence
2023-04-01 – 2023-06-3038724000 USD20240808Open filing evidence
2022-10-01 – 2022-12-3137082000 USD20240208Open filing evidence
2022-04-01 – 2022-12-31107566000 USD20240208Open filing evidence
2022-07-01 – 2022-09-3038333000 USD20231107Open filing evidence
2022-04-01 – 2022-09-3070484000 USD20231107Open filing evidence
2022-04-01 – 2022-06-3032151000 USD20230808Open filing evidence
2021-10-01 – 2021-12-3136400000 USD20220209Open filing evidence
2021-04-01 – 2021-12-31104983000 USD20220209Open filing evidence
2021-07-01 – 2021-09-3036393000 USD20211108Open filing evidence
2021-04-01 – 2021-09-3068583000 USD20211108Open filing evidence
2021-04-01 – 2021-06-3032190000 USD20220808Open filing evidence
2020-04-01 – 2021-03-31124191000 USD20210528Open filing evidence
2020-10-01 – 2020-12-3132180000 USD20220209Open filing evidence
2020-04-01 – 2020-12-3190444000 USD20220209Open filing evidence
2020-07-01 – 2020-09-3030624000 USD20211108Open filing evidence
2020-04-01 – 2020-09-3058264000 USD20211108Open filing evidence
2020-04-01 – 2020-06-3027640000 USD20210809Open filing evidence
2019-04-01 – 2020-03-31118288000 USD20210528Open filing evidence
2018-04-01 – 2019-03-31114064000 USD20210528Open filing evidence

Operatingsegmentallexceptcorpandother

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:OperatingsegmentallexceptcorpandotherMember
PeriodValueUnitFiledEvidence
2020-04-01 – 2021-03-313107519000 USD20210528Open filing evidence
2019-04-01 – 2020-03-313030895000 USD20210528Open filing evidence
2018-04-01 – 2019-03-312782170000 USD20210528Open filing evidence

Operatingsegmentall

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ste:OperatingsegmentallMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-301284542000 USD20230808Open filing evidence
2022-10-01 – 2022-12-311215994000 USD20230208Open filing evidence
2022-04-01 – 2022-12-313573002000 USD20230208Open filing evidence
2022-07-01 – 2022-09-301200517000 USD20221109Open filing evidence
2022-04-01 – 2022-09-302357008000 USD20221109Open filing evidence
2022-04-01 – 2022-06-301156491000 USD20230808Open filing evidence
2021-10-01 – 2021-12-311208971000 USD20230208Open filing evidence
2021-04-01 – 2021-12-313374378000 USD20230208Open filing evidence
2021-07-01 – 2021-09-301196985000 USD20221109Open filing evidence
2021-04-01 – 2021-09-302165407000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30968422000 USD20220808Open filing evidence
2020-04-01 – 2021-03-313107519000 USD20210528Open filing evidence
2020-10-01 – 2020-12-31808924000 USD20220209Open filing evidence
2020-04-01 – 2020-12-312233988000 USD20220209Open filing evidence
2020-07-01 – 2020-09-30756132000 USD20211108Open filing evidence
2020-04-01 – 2020-09-301425064000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30668932000 USD20210809Open filing evidence
2019-04-01 – 2020-03-313030895000 USD20210528Open filing evidence
2019-10-01 – 2019-12-31774261000 USD20210209Open filing evidence
2019-04-01 – 2019-12-312207904000 USD20210209Open filing evidence
2019-07-01 – 2019-09-30736840000 USD20201106Open filing evidence
2019-04-01 – 2019-09-301433643000 USD20201106Open filing evidence
2019-04-01 – 2019-06-30696803000 USD20200807Open filing evidence
2018-04-01 – 2019-03-312782170000 USD20210528Open filing evidence